Jan 6, 2026 06:58AM Instil Bio Inc. (TIL) Halted, News Pending

Nov 18, 2025 04:48AM Instil Bio (TIL) Shares are Fairly Valued Till Phase 2 Dose Results - Citizens

Nov 13, 2025 04:57PM Instil Bio Inc. (TIL) Misses Q3 EPS by 175c

Sep 12, 2025 06:46AM H.C. Wainwright Reiterates Buy Rating on Instil Bio Inc (TIL)

Aug 15, 2025 06:02AM Citizens JMP Reiterates Market Perform Rating on Instil Bio Inc (TIL)

Aug 13, 2025 08:43AM Instil Bio Inc. (TIL) Misses Q2 EPS by 324c

Jul 2, 2025 06:01AM Instil Bio Inc. (TIL) Announces FDA Clearance of IND Application for AXN-2510

Jun 11, 2025 07:01AM Instil Bio Inc. (TIL) Appoints John Maraganore to its Board

Jun 5, 2025 06:40AM H.C. Wainwright Reiterates Buy Rating on Instil Bio Inc (TIL)

Jun 2, 2025 07:03AM Instil Bio Inc. (TIL) Appoints Jamie Freedman as Chief Medical Officer

Jun 2, 2025 04:08AM Citizens JMP Reiterates Market Perform Rating on Instil Bio Inc (TIL)

May 30, 2025 05:01AM Citizens JMP: Standard of Care Modifying Regimens at ASCO 2025

May 23, 2025 06:37AM Instil Bio Inc (TIL) PT Raised to $125 at H.C. Wainwright

May 22, 2025 06:58AM Instil Bio Inc (TIL) PT Lowered to $105 at H.C. Wainwright

Mar 5, 2025 04:23PM Instil Bio Inc. (TIL) Misses Q4 EPS by 182c

Jan 14, 2025 07:01AM Instil Bio Inc. (TIL) Announces Clinical Progress in China for IMM2510/SYN-2510

Nov 14, 2024 06:59AM Instil Bio Inc (TIL) PT Lowered to $110 at H.C. Wainwright

Nov 4, 2024 03:27AM JMP Securities Starts Instil Bio Inc (TIL) at Market Perform

Oct 11, 2024 06:32AM Baird Reiterates Outperform Rating on Instil Bio Inc (TIL)

Sep 19, 2024 06:42AM Baird Reiterates Outperform Rating on Instil Bio Inc (TIL)

Sep 16, 2024 10:01AM Baird Reiterates Outperform Rating on Instil Bio Inc (TIL)

Sep 16, 2024 06:56AM Instil Bio Inc (TIL) PT Raised to $120 at H.C. Wainwright

Sep 13, 2024 03:33AM Instil Bio Inc (TIL) PT Raised to $180 at Baird

Sep 12, 2024 07:29AM Instil Bio Inc (TIL) PT Raised to $40 at H.C. Wainwright

Sep 9, 2024 06:26AM Baird Reiterates Outperform Rating on Instil Bio Inc (TIL)